It’s been a strong year for biotech IPOs and Wednesday shaped up to be a particularly busy day as four life science firms debuted on the public markets.
So far this year, 72 companies have gone public, according to IPO research... Read more »
Founder and CEO, Acme Packet
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Software Engineer at Skelmir
Founder and Chairman, Sycamore Networks
There’s a speed dating game of sorts happening as pharmaceutical companies that have approved cancer immunotherapies are testing their medications in combination with experimental drugs in hopes of reaching more patients.
Airbus, one of the world’s largest aircraft manufacturers, announced Monday it plans to ramp up production in coming decades with help from hologram-based virtual reality technology developed by Microsoft.
Netherlands-based Airbus says it will equip some of its aircraft and equipment... Read more »
Fiat Chrysler Automobiles has arguably been quieter on the autonomous vehicle front than Ford and GM, but this week marked a significant development for the company. FCA announced it will partner with Aurora, a Bay Area startup developing self-driving technologies.... Read more »
Academic researchers have long studied gender and racial disparities in STEM education, but they have not had widespread success in addressing these challenges. A University of Michigan professor and colleagues from 10 universities are hoping to change that.
At public research... Read more »
One of the entrants in the ultra-competitive race to develop treatments for the fatty liver disease known nonalcoholic steatohepatitis (NASH) suffered a setback in clinical testing today, but the company, Cymabay Therapeutics, still believes its drug could show promise as the... Read more »